Please complete the CAPTCHA to continue
@bms.com
✓
4 phones found area 610, 617, and 212
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Kate Hermans is listed as Chair I Board Member I Strategic Advisor I CEO I Business Builder I Pharmaceuticals I Biotech I HealthTech at Clue by Biowink, based in Wayne, Pennsylvania, United States. AeroLeads shows a work email signal at bms.com, phone signal with area code 610, 617, 212, and a matched LinkedIn profile for Kate Hermans.
Kate Hermans previously worked as Chair at Clue By Biowink and Board Member at Mid-Atlantic Diamond Ventures (Madv). Kate Hermans holds Master Of International Management, Finance from Thunderbird School Of Global Management.
This section adds company-level context without repeating Kate Hermans's masked contact details.
AeroLeads found 2 current-domain work email signals for Kate Hermans. Compare company email patterns before reaching out.
Public & Private Board Chair / Director. Advisor to biotech start-ups. Investor. C-Suite Executive with a passion for building businesses and solutions for stakeholders on the front lines of healthcare. Two successful exits with a unique ability to unlock potential and deliver exceptional financial outcomes across venture-backed and public companies.
Listed skills include Cross Functional Team Leadership, Product Launch, Strategy, Pharmaceutical Industry, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Berlin, De
Clue is a trusted reproductive health resource, protector of data privacy, and thought leader in Femtech. Developed by the Berlin-based technology company BioWink GmbH, Clue combines science and technology to actively changing the way people learn, access, and talk about menstrual and reproductive health around the world.
Philadelphia, Pennsylvania, Us
MADV is a leading organization that assists emerging, technology-based companies in their effort to build sustainable businesses by better positioning them for funding while increasing value at an early and crucial stage.
San Diego, Ca, Us
On March 7th, 2024, Johnson & Johnson successfully completed the acquisition of Ambrx for approximately $2B .Ambrx (NYSE: AMAM) - clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics in multiple cancer indications.
San Diego, Ca, Us
Led a rapid and thorough pipeline assessment which resulted in a strategic turnaround, reprioritization of new lead asset, doubling the cash runway, and streamlined corporate governance and operations. (https://www.fiercebiotech.com/biotech/esmo-ambrxs-reset-arrives-last-line-prostate-cancer-offering-not-one-serious-adverse-event)
Advisory firm for startup and early-stage enterprises that strategically positions companies to maximize their value creation.
Austin, Texas, Us
Investor and Chief Business Officer (Pharma) of a private digital health technology company focused on the patient UX for both commercial and clinical trial applications.
Boston, Ma, Us
Global biopharmaceutical company (~$200M) focused on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. Successfully launched TYMLOS™ into a highly competitive marketplace with award-winning creative campaigns. Re-engineered launch strategy while launching and exceeded Y1 revenue goals in specialty pharmacy/hub delivery model (reached 39% NBRx, 29% TRx, $99.2M by 2018 EOY).
Lawrence Township, Nj, Us
Led New Product Planning team. Set commercialization strategy for the BMS specialty portfolio. Responsible for New Product / Pipeline development, Business Development, M&A. Resulted in out licensing (GDD), partnering (CV), and acceleration (immunology, fibrosis) of select assets in the portfolio.
Lawrence Township, Nj, Us
Led the successful turnaround of Orencia® resulting in +15-20% growth YOY and +64% sales increase in 4 years. Led continued acceleration of HCV franchise, recognized by analysts for its positive impact on patients and BMS growth in the face of intense competition. Drove growth of both franchises by nearly $1B combined during tenure to $4B. Founded company’s first equity & diversity-focused executive leadership development program (LEAD).
Lawrence Township, Nj, Us
Head of Immunology pipeline commercialization. Shaped company portfolio vision through creation of robust immunology franchise strategy, laying groundwork for future BMS strategic M&A.
New York, New York, Us
Co-led global organizational redesign, creating Pfizer’s Global Commercial Operations (GCO) center of excellence in 4 months (synergized 17 groups, 1100+ colleagues and $685M in spend across commercial operations, training, multi-channel marketing, business analytics)
New York, New York, Us
Built $51M business unit and industry-leading commercial team (330 sales, marketing & operations) resulting in 150% growth in net sales and IBT for 2010. Received industry recognition for most successful multinational product launch (Prevenar®) since 1999 (IMS), through DTC innovation and public health commitments.
New York, New York, Us
Led $90M business successfully through Pfizer acquisition (800 commercial, operations, and distribution professionals). Recognized by China Pharma Industry Association (RDPAC) as the fastest growing company in China with +67% 1H09 vs. 1H08 (45% FY).
New York, New York, Us
Head of Marketing, China responsible for 5 in-line products, 1 launch product, and 5 therapeutic areas (vaccines, CNS, women’s health, antibiotics and transplant). Achieved $59M net sales (+59% vs. 2007), successfully launched Prevenar®, exceeding vaccination rate target by 28% (Q2 2009), and built organizational capability in marketing, new product planning, and market research.
New York, New York, Us
New York, New York, Us
New York, New York, Us
New York, New York, Us
Quick answers generated from the profile data available on this page.
Kate Hermans works for Clue by Biowink.
Kate Hermans is listed as Chair I Board Member I Strategic Advisor I CEO I Business Builder I Pharmaceuticals I Biotech I HealthTech at Clue by Biowink.
AeroLeads has found 2 work email signals at @bms.com for Kate Hermans at Clue by Biowink.
AeroLeads has found 4 phone signal(s) with area code 610, 617, 212 for Kate Hermans at Clue by Biowink.
Kate Hermans is based in Wayne, Pennsylvania, United States while working with Clue by Biowink.
Kate Hermans has worked for Clue By Biowink, Mid-Atlantic Diamond Ventures (Madv), Ambrx, Hermans International Llc, and 83Bar, The Patient Activation Company.
You can use AeroLeads to view verified contact signals for Kate Hermans at Clue by Biowink, including work email, phone, and LinkedIn data when available.
Kate Hermans holds Master Of International Management, Finance from Thunderbird School Of Global Management.
Kate Hermans is listed with skills including Cross Functional Team Leadership, Product Launch, Strategy, Pharmaceutical Industry, Global Marketing, Business Strategy, Strategic Planning, and Management.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts